One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The live source uses the spelling Amantidine in its heading and URL; amantadine is retained as the searchable ingredient name. This is not a modified-release amantadine protocol.
The retrieved SYMMETREL mirror uses 100 mg every 7 days below 15, while the US IR capsule label uses 200 mg every 7 days. Other interval bands and first-dose instructions also differ; mirror jurisdiction/applicability is unreconciled.
What to reconcile: Treat the SYMMETREL mirror as a source-quality hold. Do not apply its schedule to the US IR capsule or an extended-release product.
Open this note and its source referencesTreat the SYMMETREL mirror as a source-quality hold. Do not apply its schedule to the US IR capsule or an extended-release product.
The mirror headings overlap at 25 and 35. This card records a conflict rather than endorsing a second renal algorithm.
Use exact-product official labeling; low hemodialysis removal does not resolve the dose disagreement.
| Source observation | Source-specific instruction |
|---|---|
| CrCl <15 | The mirror says 100 mg every 7 days, versus 200 mg every 7 days in the US IR label. |
| Other bands / first dose | The mirror uses different interval bands and indication-specific first doses. Do not combine them with the US schedule. |
Mirror conflict - NOT the US label schedule
| Source observation | Source-specific instruction |
|---|---|
| CrCl <15 | The mirror says 100 mg every 7 days, versus 200 mg every 7 days in the US IR label. |
| Other bands / first dose | The mirror uses different interval bands and indication-specific first doses. Do not combine them with the US schedule. |
The mirror headings overlap at 25 and 35. This card records a conflict rather than endorsing a second renal algorithm.
Use exact-product official labeling; low hemodialysis removal does not resolve the dose disagreement.
RDM64-rxlist-amantidine-06b1d14b7a-C1 · Source locator: Renal Impairment Table 1, preceding first-dose paragraph and Hemodialysis.
The mirror headings overlap at 25 and 35. This card records a conflict rather than endorsing a second renal algorithm.
Use exact-product official labeling; low hemodialysis removal does not resolve the dose disagreement.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=amantidine&s1=RDM64-rxlist-amantidine-06b1d14b7a&h1=d3eb4034af89c7ed3badaec5d58c606c4e40d0260c3f6863a4e74c68e7bb0c01